secwatch.observer — SEC 8-K summary
======================================

Issuer:     Embecta Corp. (EMBC)
CIK:        0001872789
Form:       8-K
Filed at:   2023-05-12T23:59:59+00:00
Accession:  0001872789-23-000011
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Embecta beats Q2 with $277M revenue (+4% CC); raises FY2023 adj EPS guidance to $2.50-$2.60
--------------------------------------------------------------------------------

- Q2 revenue $277.1M, +4.0% constant currency; US +3.6%, international +4.4% constant currency.
- Adjusted EPS $0.75, adjusted operating margin 30.6%, adjusted EBITDA margin 34.9%.
- FY2023 guidance raised: revenue $1,101-1,113M (prev $1,084-1,107M), constant currency growth 0-1%.
- Adjusted EPS guidance raised to $2.50-2.60 from $2.20-2.35; adj gross margin ~64.5%, adj op margin ~28%.
- Declared $0.15/share quarterly dividend; advancing insulin patch pump via Tidepool collaboration for type 2 closed-loop.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1872789/000187278923000011/0001872789-23-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1872789/000187278923000011/embc-20230512.htm
  HTML page:      https://secwatch.observer/filing/0001872789-23-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer